PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
15-Apr-2021 $1.13 Bn Marine Collagen Markets, 2026 by Type (Type I, Type III), Application (Nutraceuticals, Cosmetic, Medical), Source (Skin, Scales, and Muscles, Bones & Tendons) - ResearchAndMarkets.com Businesswire
15-Apr-2021 Peter Windisch Appointed Chief Technology Officer at Excelya Businesswire
15-Apr-2021 Columbia Care Launches First of Its Kind Medical Cannabis Capsule in UK; Provides More Precise Dosing Option and Longer Lasting Therapeutic Benefits for Physicians and Patients Businesswire
15-Apr-2021 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
15-Apr-2021 Completion of the Third Clinical Trial - an Important Achievement for Medicortex Finland Businesswire
15-Apr-2021 Genentech’s Evrysdi Continues to Improve Motor Function and Survival in Babies With Type 1 Spinal Muscular Atrophy (SMA) Businesswire
15-Apr-2021 Pherecydes Pharma Announces Its 2020 Annual Financial Results and Confirms Its 2021 Outlook Businesswire
14-Apr-2021 Nexus Pharmaceuticals Makes Key Investment to Help COVID-19 Vaccine Effort Businesswire
14-Apr-2021 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of LifeMD, Inc. (LFMD) on Behalf of Investors Businesswire
14-Apr-2021 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Intrusion, Inc. (INTZ) on Behalf of Investors Businesswire
14-Apr-2021 Trinseo Announces Release Date and Conference Call for its First Quarter 2021 Financial Results Businesswire
14-Apr-2021 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Champignon Brands Inc. (SHRMF) on Behalf of Investors Businesswire
14-Apr-2021 Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cabometyx® (cabozantinib) as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma Businesswire
14-Apr-2021 Glaukos Corporation to Release First Quarter 2021 Financial Results after Market Close on May 5 Businesswire
14-Apr-2021 AbCellera and Empirico Announce Strategic Multi-Target Antibody Discovery Collaboration Businesswire
14-Apr-2021 StemSynergy Therapeutics’ Notch1-Selective Small Molecule Inhibitor Prevents Tumor Growth by Ablation of Cancer Stem Cells Businesswire
14-Apr-2021 Novo Integrated Sciences Announces Second Quarter 2021 Financial Results Businesswire
14-Apr-2021 Europe Bottled Water Market Analysis and Forecast, 2020-2021 & 2026 - ResearchAndMarkets.com Businesswire
14-Apr-2021 Asia Pacific Bottled Water Market Analysis and Forecast, 2020-2021 & 2026 - ResearchAndMarkets.com Businesswire
14-Apr-2021 North America Electronic Clinical Outcome Assessment Market 2020-2021 & 2026 - ResearchAndMarkets.com Businesswire